prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. Examination: Intraoperative examination. Gender: F. Material: Lesion excision - right breast. Internal referral. Expected time of examination: 20 minutes (from receipt of material). Clinical diagnosis: Cancer of the right breast - marked with 1 thread for sternum, 2 threads for the shoulder, 3 threads for the. axilla. Please, review the margins. Examination performed or. Result of intraoperative examination: Carcinoma invasivum mammae 1.1 cm in diameter. Final response to be given after paraffin specimens are analysed. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTest™ by DAKO. Negative reaction in invasive cancerous cells Score = 1+ ). Macroscopic description: Partial reaction of the mammary gland;. Fragment of the breast sized 6.7 x 5.7 x 3.8 cm with a skin flap of 5.3 x 1.6 cm. We marked typically. Tumour sized 1.1 x 0.6 x 0.8 cm in the cross section. Margins: 0.8 cm to the base; 1.9 cm to the skin; 3.4 cm to the edge of. sternum; 1.8 cm to the axilla, 1.4 cm to the shoulder; 1.3 cm to the lower boundary. Microscopic description: Carcinoma ductale invasivum mammae dextrae NHG1 (2 + 2 + 1/2 mitoses/10 HPF - visual area of 0.55 mm). The largest. dimension of the lesion 1.1 cm. Margins of normal tissues as in the macroscopic description. Glandular tissue showing lesions of. the type mastopathia fibrosa partim lipomatosis. Examination: Intraoperative examination. page 2 / 2. xamination No.: Gender: F. Histopathology diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. NHG1, pT1c, pNo/sn/.

expanded version (tokens=904) : 
 This breast pathology report describes the results of a biopsy of a lesion in the right breast of a female patient. Here is a breakdown of the key points:

- Histological classification: The report identifies the tumor as a "carcinoma ductale invasivum mammae" or invasive ductal carcinoma.
- Subtype: The tumor is classified as LumA, which denotes an estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+) subtype of breast cancer.
- Necrosis: There is no mention of necrosis in the report.
- Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.
- Histological grade: The histological grade is given as NHG1 or Nottingham Histologic Grade 1, which indicates a low-grade tumor.
- Nuclear grade: The report does not specify a nuclear grade.
- Lymphovascular invasion: There is no mention of lymphovascular invasion in the report.
- Calcification: There is no mention of calcification in the report.
- Receptor status: The report states that the tumor is ER+ and PR+, indicating that it is likely to respond to hormone therapy.
- IHC and ancillary testing: The tumor was tested for HER2 protein using the HercepTest™ by DAKO, and the result was negative (Score = 1+), indicating that the tumor is HER2-negative.

Overall, this report confirms the presence of a 1

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1053) : 
 The report identifies a 1.1 cm invasive ductal carcinoma in the right breast of a female patient, classified as LumA subtype. The histological grade is NHG1, indicating a low-grade tumor. Estrogen and progesterone receptors are found in over 75% of neoplastic cell nuclei, while HER2 protein is negative. Margins are clear of cancer cells and there is no mention of necrosis, tumor infiltrating lymphocytes, lymphovascular invasion or calcification.

